THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU WHICH IS PART OF DOMESTIC UK LAW PURSUANT TO THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS (SI 2019/310) ("UK MAR"). UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION (AS DEFINED IN UK MAR) IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.
16 September 2025
ICFG LIMITED
("ICFG" or the "Company")
Loan Note Instrument
ICFG (LON: ICFG), announces that the Company has raised an initial £330,000 through the issuance of loan notes via an unsecured loan note instrument dated 15 September 2025 (the "Series A Loan Notes").
The Series A Loan Notes will be issued in denominations of £10,000 (or multiples thereof) under certificates subscribed by noteholders up to a maximum of £1 million. The Series A Loan Notes carry a fixed interest rate of 10 per cent per annum, with the principal amount and accrued interest repayable 12 months from the date of issue under the relevant certificate. The Series A Loan Notes have no conversion rights.
Proceeds from the Series A Loan Notes will be used for the Company's general working capital purposes, providing additional flexibility to support the Company's operations and future opportunities.
On 15 September 2025, the first tranche of Series A Loan Notes was subscribed by IVCH SG PTE Ltd, a Singapore-based entity owned and controlled by Hirohito Namiki, board director and shareholder of the Company. IVCH SG PTE Ltd subscribed for £330,000 of Series A Loan Notes, and the Company has accordingly issued 33 Series A Loan Notes.
The Company will make further announcements in due course, as appropriate.
For further information, please contact:
| ICFG Limited Via IFC Enkhmaral Batkhuyag, Interim CEO
|
| Strand Hanson Limited (Financial Adviser) Rory Murphy / Abigail Wennington / David Asquith +44 (0) 207 409 3494
|
| Novum Securities (Broker) Jon Bellis / Colin Rowbury +44 (0) 207 399 9400
|
| IFC Advisory Limited (Financial PR and IR) Tim Metcalfe / Zach Cohen +44 (0) 203 934 6630 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.